Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank
March 02, 2021 08:30 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., March 02, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the closing of a debt facility on February 26, 2021, with Silicon Valley Bank,...
Liquidia Corporation Announces Chief Executive Officer Transition
December 14, 2020 09:28 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of...
Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer
November 30, 2020 07:15 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective...
Liquidia Receives Complete Response Letter from FDA for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
November 25, 2020 07:00 ET
|
Liquidia Technologies, Inc.
CRL does not cite need for additional clinical studies CRL focuses on drug CMC and device biocompatibility information Conference Call Scheduled for Today at 9:00a.m. ET RESEARCH TRIANGLE PARK,...
Liquidia Closes Acquisition of RareGen
November 18, 2020 16:01 ET
|
Liquidia Technologies, Inc.
Merger Reinforces Company’s Commitment to Patients with PAH Paul Manning and Roger Jeffs Join Liquidia Corporation Board of Directors RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2020 (GLOBE...
Liquidia Announces Results of Special Meeting of Stockholders
November 16, 2020 07:15 ET
|
Liquidia Technologies, Inc.
Stockholders Approve RareGen Acquisition Merger Expected to Close on or About November 18, 2020 RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc....
Liquidia to Present at the 2020 Jefferies Virtual London Healthcare Conference
November 12, 2020 10:06 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
November 09, 2020 07:15 ET
|
Liquidia Technologies, Inc.
- Raised $75 Million through Underwritten Public Offering- Bolstered and Defended LIQ861 Patent Position- Advanced Efforts in Support of the RareGen, LLC Merger and Integration- Company to Host...
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC
November 02, 2020 07:15 ET
|
Liquidia Technologies, Inc.
Company Determines Unsolicited Offer does not Constitute Superior Proposal RESEARCH TRIANGLE PARK, N.C, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage...
UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020
October 30, 2020 20:40 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and...